- Your Challenges
- News & Events
- Knowledge Center
- About Us
Since October 1, 2017:
This year’s flu outbreak only continues to intensify, with the majority of cases being the H3N2 strain.1
As more patients present to your waiting rooms, more strain is put on your organization. Long wait times hurt patient satisfaction, growing patient volumes put additional pressure on staff, and the inability to obtain timely test results can impede the delivery of high-quality care.
Complications due to influenza can arise quickly. This means your team needs to rapidly assess patients so you can direct your resources where they are needed most. Influenza patients of all ages are at risk of developing worsening conditions. Influenza can progress quickly—leading to complications such as pneumonia, sepsis and increased risk of mortality. Chances of a heart attack are increased six-fold during the first seven days after a flu infection.2
Transform the evaluation of metabolic status and renal function
Transform the evaluation of respiratory complications and risk stratification of sepsis
References: 1. Influenza (Flu). Centers for Disease Control and Prevention. https://www.cdc.gov/flu/weekly/summary.htm. Published February 2, 2018. Accessed February 7, 2018. 2. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. New England Journal of Medicine. 2018;378(4):345-353.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The page you are trying to access is best viewed on a desktop or laptop computer.